• 2009

Company Description

Incarda Therapeutics develops treatments for cardiovascular diseases.

InCarda Therapeutics, Inc., a product-focused cardiovascular company, develops transformative therapies for patients to use in the first moments of acute cardiovascular symptoms. It develops an inhaled therapy to treat Paroxysmal atrial fibrillation. The company was formerly known as Pleiades Cardio-Therapeutics, Inc. InCarda Therapeutics, Inc. was incorporated in 2009 and is based in Palo Alto, California.